This from our colleagues Alik Farber, Matt Menard and Ken Rosenfeld. Likely to be a game-changer in how patients with CLTI are addressed. The first results from the BEST-CLI randomised controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV) is a more effective revascularisation strategy for patients with chronic limb-threatening ischaemia (CLTI) who are deemed to be suitable... Continue Reading →